Protein Sequencing Market to Grow with a CAGR of 8.46% through 2030
The growing
advancement in mass spectroscopy and NGS and increased investment in
personalized medicine is expected to drive the Global Protein Sequencing Market
growth in the forecast period, 2026-2030.
According to
TechSci Research report, “Protein Sequencing Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030”, the
Global Protein Sequencing Market stood at USD 1.56 billion in 2024 and is
anticipated to grow with a CAGR of 8.46% in the
forecast period, 2026-2030. The
Protein Sequencing market is experiencing significant growth driven by a continuous
improvement in mass spectrometry (MS) technologies, including enhanced
sensitivity, accuracy, and the ability to handle complex proteomic data.
The protein
sequencing market is experiencing rapid growth due to the increasing demand for
advanced diagnostic tools and the growing emphasis on personalized medicine. As
healthcare providers and researchers seek to understand the complex
relationships between proteins and diseases, protein sequencing technologies
have become vital for drug development, biomarker discovery, and precision
diagnostics. Proteomics, which involves the large-scale study of proteins,
plays a key role in identifying disease-specific biomarkers and therapeutic
targets. Technologies like mass spectrometry, next-generation sequencing (NGS),
and other proteomic tools are driving the market by offering high-throughput
and accurate protein analysis. The ability to analyze vast amounts of protein
data with these technologies is transforming healthcare, enabling the
development of tailored therapies that address the unique needs of individual
patients.
Additionally,
the increasing adoption of artificial intelligence (AI) and machine learning
(ML) in protein sequencing is revolutionizing the market. AI algorithms are
improving the speed and accuracy of protein data analysis, helping to predict
protein structures, functions, and interactions. These advancements are
accelerating research in drug discovery and advancing the understanding of
complex diseases such as cancer, Alzheimer's, and cardiovascular disorders. As
the cost of sequencing continues to decrease and technology improves, protein
sequencing is becoming more accessible to academic institutions, healthcare
providers, and pharmaceutical companies worldwide. The combination of
technological innovations and the growing demand for personalized healthcare is
expected to drive significant market expansion in the coming years.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Protein Sequencing Market”
Global Protein
Sequencing Market is segmented into product & service, application, end use,
regional distribution, and company.
Based on product
& service, the protein sequencing service shows the
fastest growth over the forecast period due to increasing demand for
high-quality, specialized services that assist in research, clinical
applications, and drug development. These services are typically offered by
contract research organizations (CROs), diagnostic labs, and biotechnology
companies, providing researchers and healthcare providers with comprehensive
proteomics solutions. The demand for protein sequencing services is driven by
the complexity of protein analysis, which requires advanced technologies,
expert interpretation, and specialized tools that may not be available in-house
for many institutions or companies. This segment includes services such as
protein identification, biomarker discovery, functional proteomics, and
targeted protein analysis, which are critical for understanding disease
mechanisms, identifying new drug targets, and personalizing treatments.
Based on region, Europe is
expected to witness significant growth in the protein sequencing market over
the forecast period, driven by a combination of advanced healthcare
infrastructure, increasing investment in research and development, and growing
demand for personalized medicine. European countries, particularly those with
robust biotech industries such as Germany, the United Kingdom, and France, are
at the forefront of adopting cutting-edge protein sequencing technologies. The
region’s well-established healthcare systems are increasingly focused on
precision medicine, which relies on protein sequencing for identifying
biomarkers and developing tailored treatments. Additionally, government
initiatives and funding programs aimed at boosting research in genomics and
proteomics further support market expansion. The growing
number of clinical trials, academic collaborations, and biotechnology companies
in Europe also contribute to the market’s growth. European research
institutions are increasingly leveraging protein sequencing technologies for
drug discovery, disease modeling, and biomarker identification, particularly in
oncology, neurodegenerative diseases, and cardiovascular disorders.
Furthermore, the adoption of next-generation sequencing (NGS) and mass spectrometry
in clinical diagnostics is becoming more widespread, further fueling market
demand. As Europe continues to focus on advancing life sciences research and
personalized healthcare, the protein sequencing market is set to experience
significant growth, positioning the region as a key player in the global
proteomics landscape.
Major companies
operating in Global Protein Sequencing Market are:
- Thermo
Fisher Scientific Inc.
- Shimadzu Corporation
- Agilent Technologies, Inc.
- Rapid Novor, Inc.
- Charles River Laboratories
- Proteome Factory AG
- Selvita
- Bioinformatics Solutions Inc.
- Creative Proteomics
- Alphalyse
Download Free Sample Report
Customers can
also request for 10% free customization on this report
"The
growing demand for personalized medicine and precision diagnostics is
significantly driving the expansion of the protein sequencing market. As
researchers and healthcare providers seek to better understand disease
mechanisms at a molecular level, the integration of advanced technologies such
as mass spectrometry, next-generation sequencing, and artificial intelligence
is becoming increasingly vital. Furthermore, the increasing focus on early
disease detection and personalized treatment plans has underscored the need for
highly accurate and scalable protein sequencing solutions. As the market
continues to advance, the continued integration of cutting-edge technologies
will be crucial in transforming healthcare, offering more effective,
individualized treatment options for patients with complex medical
conditions," said Mr. Karan Chechi, Research Director of TechSci Research,
a research-focused management consulting firm.
“Protein Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Protein Sequencing Products, Reagents & Consumables, Instruments, Software, Protein Sequencing Services), By Application (Bio-therapeutics, Genetic Engineering, Others), By End Use (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology, Others), By Region & Competition 2020-2030F”, has evaluated
the future growth potential of Global Protein Sequencing Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Protein Sequencing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com